Zensights LLC
Andrew Shales is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Principal at Zensights LLC since January 2024, focusing on connecting BioPharma Commercial Operations with Best in Class partnerships. Previously, Andrew held the position of Chief Executive Officer at Resilia Pharmaceuticals, Inc. from December 2020 to January 2024, and was a Partner at Peak Pharma Partners from March 2019 to January 2024. Andrew also led Shales & Associates, a consulting firm specializing in commercial solutions for start-ups and small to medium-sized pharma/biotech companies, from October 2007 to December 2023. Andrew's extensive experience includes roles such as General Manager at Galen US Inc., Senior Director of Marketing at Exact Sciences, and Senior Vice President of Sales & Marketing at Auriga Laboratories and Synthon Laboratories. Andrew's educational background includes a Master of Science in Pharmaceutical & Medical Device Law & Compliance from Seton Hall University School of Law, expected to complete in June 2025, and a Bachelor of Arts in Psychology from King’s College.
This person is not in the org chart
This person is not in any teams
Zensights LLC
Zensights partners with commercial teams, finance, and procurement within large and emerging pharmaceutical and biotech companies. Zensights solutions combine our proprietary software tools and informational resources about business and clinical operations with the fresh perspectives of our robust Zensights Executive Network and our seasoned Executive Leadership Team. This combination allows us to vet potential vendors and implement creative customer-centric solutions based on our best-in-class playbooks. Our solutions go beyond uncovering the right vendors for our clients’ delivery of commercial services; they also identify the “A-Team” resources within each vendor organization. We provide insights and implementations that our clients need and cannot get anywhere else – demonstrated through higher ROIs and savings, and transparent, synergistic vendor relationships.